AstraZeneca

Global Clinical Head - Executive Director – Vaccines & Immune Therapies


PayCompetitive
LocationGaithersburg/Maryland
Employment typeFull-Time

This job is now closed

  • Job Description

      Req#: R-159038

      Opportunity : Global Clinical Head - Executive Director – Vaccines & Immune Therapies

      Locations: Gaithersburg (US), Cambridge, (UK), Gothenburg, (Sweden)

      Salary: Competitive, with excellent company benefits

      Are you a clinical research expert ready for new opportunities? Would you like to play a pivotal role in the development of potential medicines? If you are passionate about being a medical leader for a cross-functional team in a group that drives action towards the improvement of global public health– join us!

      At AstraZeneca we work together across global boundaries to make an impact and find answers to challenges. We do this with integrity, even in the most difficult situations because we are committed to doing the right thing.

      As Global Clinical Head you will have a unique opportunity to further elevate the Vaccines and Immune Therapies franchise in one of the world’s most respected bio-pharmaceutical companies. The role holds a significant development opportunity for the successful candidate whilst contributing to the positive journey that AstraZeneca is on.

      Main Duties and Responsibilities

      The Global Clinical Head (GCH) will have overall clinical leadership of one or more global teams and will deliver a portion of the Vaccines and Immune Therapies pipeline. The GCH is also responsible for Medical Scientific strategies for clinical components of the Target Product Profile (TPP), Clinical Development Plan (CDP) and core labelling texts and will provide medical input into commercial activities and the scientific component of the pricing and value strategy. Within the Clinical Project Team, the GCH has accountability for the clinical, scientific and value content and delivery of the Medical Science components for the Program to time and quality. The GCH will be the team’s voice and representative at the Global Franchise Team that oversees the overall strategy of Infection products.

      Typical Accountabilities:

      • Overall clinical, scientific & value content for an assigned portion of the Program.

      • Support the Clinical Project Team leading in rapidly implementing new processes and systems and sharing/seeking learning through their Portfolio of Projects.

      • Medical prioritization of clinical activities.

      • Single point accountable leader for the design, delivery and interpretation of clinical studies ensuring the ethical and scientific integrity of the plans, studies and products in compliance with GCP.

      • Ensure internal and external peer review of potential study/program design. As available, provide clinical strategic input to in-licensing opportunities.

      • Broad leadership role across the business.

      • Support as appropriate within the Program during issue and crisis management as directed by the Therapeutic Area Head for Infection.

      • Timely provision of Medical Scientific strategies for clinical components of the TPP, CDP, and core labelling texts.

      Essential Requirements:

      • Graduate of a recognized school of medicine with an M.D. degree or equivalent.

      • Demonstrated clinical research expertise in Infectious Diseases.

      • Experience in Phase 3 program development and trial conduct, as well as NDA/BLA submissions strongly desired.

      • Demonstrated ability to lead the development of project strategy and be accountable for project plans, timelines, progress, and outcomes.

      • Demonstrated ability leading and motivating teams in a matrix environment.

      • Demonstrated ability to lead, coach, and mentor junior physicians/scientists.

      • Significant hands-on clinical drug development experience and scientific credibility.

      • Experience of Clinical/commercial interface.

      • Benefit/risk assessment and creating PRMP/ BRATs.

      • Global regulatory submissions and interacting with major Health Authorities.

      • Developed/delivered in parallel, composed of multiple complex and large studies (e.g., including but not limited to multinational outcome studies).

      • Demonstrated ability to cultivate excellent cross-functional collaborations.

      • Demonstrated ability to effectively communicate at multiple levels of the organization.

      • Must demonstrate high integrity.

      • Organize and deliver Advisory Boards with international Key Opinion Leaders (KOLs).

      Desirable Requirements

      • Named Investigator on a number of clinical trials.

      • Progressed compounds into FTIM and delivered Proof of Principle.

      • Significant and consistent peer-reviewed publication track record.

      So, what’s next?

      Please complete your application via the link provided.

      Where can I find out more?

      Follow AstraZeneca on LinkedIn https://www.linkedin.com/company/1603/

      Follow AstraZeneca on Facebook https://www.facebook.com/astrazenecacareers/

      Follow AstraZeneca on Instagram https://www.instagram.com/astrazeneca_careers/?hl=en

      #V&I

      Date Posted

      14-Feb-2024

      Closing Date

      29-Apr-2024Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

      AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.
  • About the company

      AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England.